<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Human milk feeding and fortification of human milk for premature infants
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Human milk feeding and fortification of human milk for premature infants
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Human milk feeding and fortification of human milk for premature infants
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Margaret G Parker, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Steven A Abrams, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 26, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mother's own milk is the preferred feeding source for premature infants because it is associated with an array of important short- and longer-term health benefits [
         <a href="#rid1">
          1,2
         </a>
         ]. Pasteurized milk from a human donor should be given when mother's milk is not available or is contraindicated [
         <a href="#rid3">
          3
         </a>
         ]. While donor milk may reduce the risk of necrotizing enterocolitis (NEC), it does not confer many of the other important health benefits of mother's own milk.
        </p>
        <p>
         The nutritional requirements of preterm infants cannot be met with exclusive human milk feedings, because they require more protein, energy, fatty acids, minerals, and micronutrients than do healthy term newborns. For this reason, human milk fortification is needed. There are many commercially available fortifiers that vary by form (powder versus liquid), macronutrient content, degree of hydrolysis of proteins, and source (bovine versus human).
        </p>
        <p>
         This topic review will discuss health benefits of human milk (mother's milk and donor milk) and human milk fortification, including fortifier types and timing of administration. Other topics with related information are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5047.html" rel="external">
          "Nutritional composition of human milk and preterm formula for the premature infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5014.html" rel="external">
          "Approach to enteral nutrition in the premature infant"
         </a>
         .) – Focuses on enteral feeds in the neonatal intensive care unit
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5044.html" rel="external">
          "Breast milk expression for the preterm infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5035.html" rel="external">
          "Breastfeeding the preterm infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5003.html" rel="external">
          "Growth management in preterm infants"
         </a>
         .) – Focuses on feeding after neonatal intensive care unit discharge
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          BENEFITS OF MOTHER'S MILK
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mother's milk contains a range of biologic components, including immunoglobulins, cytokines, growth factors, hormones, and prebiotic oligosaccharides, that confer health benefits compared with formula feeds [
         <a href="#rid4">
          4,5
         </a>
         ]. Benefits of mother's milk for the infant include improvements in gastrointestinal function, digestion and absorption, cognitive and visual development, and host defense as well as enhanced maternal-infant bonding. (See
         <a class="medical medical_review" href="/z/d/html/5013.html" rel="external">
          "Infant benefits of breastfeeding"
         </a>
         .)
        </p>
        <p>
         Particular benefits for premature infants include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protection against necrotizing enterocolitis (NEC)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protection against late-onset sepsis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protection against chronic lung disease
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Improved neurodevelopment
        </p>
        <p>
        </p>
        <p>
         In general, the greater the proportion of mother's milk in the diet (versus formula), the stronger the association with these health benefits. The evidence for these benefits is summarized below and described in more detail in the linked topic reviews.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Protection against NEC
         </strong>
         – Feeding mother's milk to a premature infant significantly decreases the incidence of NEC compared with formula feeding [
         <a href="#rid6">
          6-9
         </a>
         ]. The evidence is discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">
          "Neonatal necrotizing enterocolitis: Prevention", section on 'Human milk feeding'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Human milk components that appear to protect against NEC include immunoglobulins, acetylhydrolase (which antagonizes platelet-activating factor, a major trigger for NEC in premature infants), and human milk oligosaccharides (which promote the growth of a healthy gut microbiome). (See
         <a class="medical medical_review" href="/z/d/html/4991.html" rel="external">
          "Neonatal necrotizing enterocolitis: Pathology and pathogenesis", section on 'Human milk'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Protection against infection
         </strong>
         – Some studies show that premature infants fed mother's milk have reduced rates of late-onset sepsis [
         <a href="#rid10">
          10-12
         </a>
         ]. Possible explanations for these beneficial effects include [
         <a href="#rid4">
          4
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Presence of maternal antibodies in human breast milk (ie, secretory immunoglobulin A [sIgA] and other immunoglobulins provided by the enteromammary immune system). Skin-to-skin contact between mother and infant may also elicit maternal antibodies to nosocomial pathogens.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mother's milk feeding may decrease the proportion of pathogenic microorganisms in infant fecal flora.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mother's milk also contains other factors that may be important in host defense, including lactoferrin, lysozyme, oligosaccharides, cytokines, enzymes, growth factors, nucleotides, and cellular components.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Improved neurodevelopment
         </strong>
         – Several studies of hospitalized preterm infants have shown that consumption of mother's milk, compared with preterm formula, is associated with improved neurodevelopment in a dose-response relationship [
         <a href="#rid1">
          1,13-17
         </a>
         ]. These benefits were observed even when mother's milk was associated with slower growth, although slower growth is generally associated with worse neurodevelopment. However, some other studies and a meta-analysis did not detect such an effect [
         <a href="#rid8">
          8,9,18
         </a>
         ]. Reasons for the discrepant findings may include sample size, adjustment for comorbidities, and differences in categories of exposure to mother's milk (eg, exclusively mother's milk versus "mostly" mother's milk).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Mechanisms that may explain the relationship between mother's milk consumption and improved neurodevelopment include biologic components of mother's milk that may contribute to brain growth [
         <a href="#rid19">
          19
         </a>
         ] and mother-infant bonding, which has been linked to mother's milk feeding and promotes improved neurodevelopment among preterm infants.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Protection against chronic lung disease
         </strong>
         – Several studies have found a dose-dependent reduction in chronic lung disease among preterm infants fed mother's own milk during the birth hospitalization [
         <a href="#rid1">
          1
         </a>
         ]. Proposed mechanisms include increased delivery of bioactive components of mother's milk that reduce oxidative stress and inflammation in the premature lung and/or reduced incidence of NEC and sepsis, which contribute to development of chronic lung disease. (See
         <a class="medical medical_review" href="/z/d/html/4992.html" rel="external">
          "Bronchopulmonary dysplasia (BPD): Prevention", section on 'Breast milk'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3750441842">
         <span class="h1">
          USE OF DONOR MILK
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many mothers are unable to provide sufficient mother's milk to meet the needs of their preterm infant during the birth hospitalization and following discharge. In the United States, approximately one-half of very low birth weight (VLBW) infants were being fed human milk (primarily mother's own milk but sometimes donor human milk) at the time of hospital discharge [
         <a href="#rid20">
          20
         </a>
         ]. Because mother's own milk has the most health benefits for the infant, every effort should be made to support effective lactation by the birth mother [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5044.html" rel="external">
          "Breast milk expression for the preterm infant"
         </a>
         .)
        </p>
        <p>
         When mother's own milk is not available or is insufficient, pasteurized human milk from a donor may be used. Donor milk also may be used as a "bridge" until the mother's milk supply improves with time and intensive lactation support.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications for donor milk
         </strong>
         – Pasteurized human donor milk should be used when mother's milk is not available for VLBW infants (&lt;1500 g), as recommended by guidelines from the American Academy of Pediatrics [
         <a href="#rid2">
          2,3
         </a>
         ] and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition [
         <a href="#rid21">
          21
         </a>
         ]. Some neonatal intensive care units also use human donor milk for infants above 1500 g [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If donor human milk is used, it may be given to preterm infants as soon as they are deemed able to tolerate enteral feedings. There are no clear guidelines for when to discontinue the use of donor human milk, but common practice is to continue until the infant reaches approximately 34 weeks postmenstrual age, weighs 2000 g, and/or is ready for hospital discharge [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rationale
         </strong>
         – Donor milk (when provided exclusively or as a supplement to mother's own milk) is associated with decreased risk of necrotizing enterocolitis (NEC) and feeding intolerance compared with preterm formula [
         <a href="#rid1">
          1,23-25
         </a>
         ]. By contrast, benefits of donor milk on neurodevelopment, or risk for late-onset sepsis, chronic lung disease, or retinopathy of prematurity, have not been demonstrated [
         <a href="#rid23">
          23,24,26
         </a>
         ]. Explanations for the apparent advantage of mother's own milk are that donor milk has reduced bioactivity due to the pasteurization process, multiple freeze-thaw cycles, container changes, and prolonged storage times.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Safety
         </strong>
         – Due to the vulnerable medical status of premature infants, donor milk should always be obtained from an established human milk bank that follows safety regulations for optimal milk collection, pasteurization, storage, and shipping [
         <a href="#rid27">
          27,28
         </a>
         ]. In North America, accredited nonprofit human milk banks can be found through the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.hmbana.org%2F&amp;token=z%2Bmt1N5aL9bgwch2eXBa3gHz%2BF0%2Fxp5aOErzHau23VY%3D&amp;TOPIC_ID=5050" target="_blank">
          Human Milk Banking Association of North America
         </a>
         ; several for-profit companies also sell appropriately processed donor milk. Safety standards are also maintained by central organizations in many other countries or regions, including the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fukamb.org%2F&amp;token=GpuWEF2nKV%2BhvlhgnR%2BNnUTtaCM9VjSe5VHQONvgB%2B8%3D&amp;TOPIC_ID=5050" target="_blank">
          United Kingdom Association for Milk Banking
         </a>
         , the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Feuropeanmilkbanking.com%2F&amp;token=TDSg%2BO4gd3c1hR2Cc3NN%2Fo4O7fqrcaoex5DWc6FGA1XrlMtrmOH%2FcOyGUk1LPTyw&amp;TOPIC_ID=5050" target="_blank">
          European Milk Bank Association
         </a>
         , and
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Frblh.fiocruz.br%2Fpagina-inicial-rede-blh&amp;token=4NrSrXbqmIQFCAibRY626WiNs4TTJOZKMibeBGUK2y9DLc8r9vzwHajHyEth0uNiSIbRNaiXCLdoADNagtOPSA%3D%3D&amp;TOPIC_ID=5050" target="_blank">
          Banco de Leite Humano in Brazil
         </a>
         . Information for some other countries and regions can be found at the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.path.org%2Fprograms%2Fmaternal-newborn-child-health-and-nutrition%2Fhuman-milk-banking-resources-page%2F&amp;token=JRdy7h%2FdZnLiID0nMxcgxEdJZxM0cjygjR8K6COHAgwk7wUpoJ3FIqlos6hOgEWufqbFJnYRmyTyEzaCGElwKEFvGIssflt8yhKSp0pKcKWIoBdnRwvLMv0AqYSNK%2BZf&amp;TOPIC_ID=5050" target="_blank">
          PATH human milk banking resources page
         </a>
         . Donor milk obtained over the internet and/or that is not pasteurized by an established milk bank should not be used.
        </p>
        <p>
        </p>
        <p>
         Some Muslim families may be reluctant to use pooled human donor milk due to Islamic belief about milk kinship, although the interpretation varies among different Muslim communities. This issue calls for culturally sensitive conversations to help the family make a fully informed decision and explore alternatives to pooled donor milk, if needed [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          GROWTH LIMITATIONS OF HUMAN MILK
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although human milk is the optimal diet for preterm infants, a human milk fortifier (HMF) must be added so that it delivers sufficient nutrients to meet the infants' needs. Unfortified human milk does not supply sufficient quantities of protein, energy, fatty acids, minerals, and other micronutrients that are needed for preterm infants to achieve fetal growth trajectories [
         <a href="#rid30">
          30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5047.html" rel="external">
          "Nutritional composition of human milk and preterm formula for the premature infant"
         </a>
         .)
        </p>
        <p>
         Although preterm mother's milk has more protein and energy than term milk, the content of these macronutrients is still less than the recommended needs for preterm infants  (
         <a class="graphic graphic_table graphicRef111650" href="/z/d/graphic/111650.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid31">
          31,32
         </a>
         ]. The protein deficit is particularly severe for donor milk, which is predominantly derived from pooled samples of mothers of term infants who donate milk that is pumped several months after birth [
         <a href="#rid33">
          33
         </a>
         ]. Further, the process of pasteurization can reduce lipase activity, which may decrease the fat digestibility and further inhibit growth [
         <a href="#rid34">
          34
         </a>
         ]. The deficit in energy is also exacerbated because preterm infants typically receive their feedings via naso- or orogastric tubes. This mode of delivery decreases nutrient delivery to the infant because the fats stick to the tubing, particularly when the feed is infused at slower rates [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
         Multiple observational and randomized trials have shown that preterm infants fed preterm formula have more rapid growth during the hospital period than those fed mother's milk and/or donor milk, even when an HMF is used [
         <a href="#rid25">
          25,36
         </a>
         ]. Nonetheless, human milk feeding (with appropriate fortification) is associated with faster attainment of full feeds and earlier neonatal intensive care unit discharge in some centers, presumably because of its benefits for feeding tolerance and protective effect against comorbidities [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          FORTIFICATION OF HUMAN MILK
         </span>
        </p>
        <p class="headingAnchor" id="H4135958896">
         <span class="h2">
          Indications and fortifier types
         </span>
         <span class="headingEndMark">
          —
         </span>
         Human milk feeds for hospitalized very low birth weight (VLBW) infants and other infants at risk for growth failure should be supplemented with multinutrient human milk fortifier (HMF) [
         <a href="#rid1">
          1,38
         </a>
         ]. HMFs are designed to be mixed with human milk prior to administration. Multiple fortifiers are commercially available, which vary in several ways  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Liquid versus powder form
         </strong>
         – Bovine-derived HMFs come in powder and liquid forms. We and many other institutions use liquid rather than powdered fortifiers because of case reports of transmission of
         <em>
          Cronobacter sakazakii
         </em>
         in powdered fortifiers or formulas (including an incident in February 2022 involving powdered formulas from a specific facility) [
         <a href="#rid39">
          39-42
         </a>
         ]. Products in a powder form cannot be sterilized in the same manner as liquids and, thus, are at risk for bacterial contamination, although the risk is very low due to manufacturing standards and extensive testing. Powdered HMFs are commonly used outside of the United States, with minimal safety problems. Moreover, it should be recognized that bovine liquid HMFs displace the volume of human milk given to the infant and thus reduce the proportion of human milk in the diet compared with powdered HMFs [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Protein content
         </strong>
         – Commercially available HMFs generally provide at least moderate- or high-protein supplements, adding between 1 and 2.2 g of protein per 100 mL final volume to provide a total protein content between 2.6 and 3.5 g/100 mL of fortified human milk  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 2
         </a>
         ). Limited evidence suggests that those on the higher end of this range (adding ≥1.4 g/100 mL final volume) may result in modest increases in weight gain (mean difference 0.7 g/kg/day) during the neonatal admission compared with HMFs with protein content on the lower end of this range (adding 1 to &lt;1.4 g/100 mL) [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Protein structure (intact versus hydrolyzed)
         </strong>
         – Bovine HMFs also vary in the extent to which the proteins are hydrolyzed. Hydrolyzed protein fortifiers are thought to be more readily absorbed in the preterm gut and therefore lead to improved feeding tolerance with higher concentrations of protein. One randomized trial of 150 preterm infants compared powdered HMF with a hydrolyzed liquid HMF with 20 percent more protein content and found similar feeding tolerance and improved growth among the infants fed hydrolyzed HMF [
         <a href="#rid45">
          45
         </a>
         ]. This finding and others provide evidence in support of hydrolyzed HMF over powdered fortifiers with nonhydrolyzed protein; however, the difference in the growth outcome may be related to the lower protein content of the powdered HMF rather than the hydrolysis. There are no randomized controlled trials comparing forms of HMFs with hydrolyzed versus intact proteins but with similar protein content.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acidified versus non-acidified
         </strong>
         – For some liquid HMFs, the sterilization process involves acidification followed by heat treatment. These forms of HMFs have been associated with transient metabolic acidosis in preterm infants but not changes in growth, so the clinical relevance of this factor is unclear [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bovine versus human
         </strong>
         – Another type of HMF is derived from pasteurized human donor milk (human milk-derived HMF). The relative advantages of human-derived HMF compared with bovine-derived HMF have not been fully explored. In a randomized trial, the risk of necrotizing enterocolitis (NEC) and growth parameters were not statistically different among very preterm infants who were fed human milk supplemented with bovine-derived HMF compared with human milk-derived HMF [
         <a href="#rid47">
          47
         </a>
         ]. However, a subsequent meta-analysis that included this and two other trials found that use of a bovine-derived HMF led to significantly worse outcomes for NEC, retinopathy of prematurity, interruption of feeding, and a composite morbidity index [
         <a href="#rid48">
          48-50
         </a>
         ]. Potential concerns about human milk-derived HMFs are the high cost, disparate access to these products across different institutions and countries, and displacement of the volume of mother's milk given to the infant (the latter issue also applies to bovine-derived liquid HMFs). Although some centers consider the cost of these products to be prohibitive, an analysis suggests an overall cost savings when considering the high cost of NEC and other comorbidities [
         <a href="#rid51">
          51
         </a>
         ]. Until the comorbidity outcomes are confirmed and these issues are addressed, the author does not recommend human-derived HMF for general use in neonatal intensive care units, but this remains an area of controversy and ongoing investigation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Micronutrient content
         </strong>
         – Micronutrient and vitamin content of HMFs may vary, and, therefore, individualization of supplements might be needed. All HMFs are designed to provide supplemental calcium and phosphorus to meet the high needs of a premature infant, but the content of these minerals differs somewhat among the HMFs available in the United States and also compared with those available in Europe. (See
         <a class="medical medical_review" href="/z/d/html/5047.html" rel="external">
          "Nutritional composition of human milk and preterm formula for the premature infant", section on 'Electrolytes, trace elements, minerals, and vitamins'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5056.html" rel="external">
          "Management of bone health in preterm infants", section on 'Calcium and phosphorus requirements'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lipid
         </strong>
         – The fat content also varies among HMFs. Powdered HMFs typically contribute an additional 0.35 to 1 g lipid per 100 mL of prepared milk in addition to the lipid content of the human milk itself, and liquid HMF can add as much as 2.3 g lipid per 100 mL of prepared milk [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3942310192">
         <span class="h2">
          In-hospital fortifier use
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal timing to initiate fortification has not been established. Many neonatal intensive care units initiate fortification when feeding volumes reach 80 to 100 mL/kg/day, but some initiate fortification at lower feeding volumes [
         <a href="#rid1">
          1
         </a>
         ]. Several studies found that adding a human milk-derived HMF beginning at a feeding volume of 20 to 40 mL/kg/day was not associated with feeding intolerance or NEC [
         <a href="#rid23">
          23,53,54
         </a>
         ].
        </p>
        <p>
         Fortification is typically continued throughout the preterm infant hospitalization, and titration of fortifiers should be based on growth and other markers of nutritional status. This is particularly important among preterm infants fed predominantly or exclusively donor milk, which has lower protein and energy content compared with mother's milk (see
         <a class="medical medical_review" href="/z/d/html/5014.html" rel="external">
          "Approach to enteral nutrition in the premature infant"
         </a>
         ). Point-of-care analyzers that measure the macronutrient content of milk are available for clinical use in some institutions. The use of these tools to facilitate individual fortification strategies is emerging [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Examples of the macronutrient content of fortified human milk is shown in the table, based on average content of preterm milk and HMFs commonly used in the United States  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H1844519718">
         <span class="h2">
          Post-discharge fortifier use
         </span>
         <span class="headingEndMark">
          —
         </span>
         More than one-half of VLBW infants have extrauterine growth failure (weight for gestational age less than 10
         <sup>
          th
         </sup>
         percentile) at hospital discharge [
         <a href="#rid56">
          56
         </a>
         ]. Many providers recommend that fortification be continued after discharge home to support ongoing "catch-up growth." However, studies of this practice on growth and neurodevelopment outcomes are lacking [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Decisions about fortifier use should optimally be made in conjunction with maternal goals for lactation, bottle feeding with expressed milk, fortifier versus formula, and the infant's growth status. For example, if a mother would like to breastfeed directly, the first step might be to transition some feeds to direct breastfeeding while maintaining other feeds of expressed mother's milk with HMF prior to hospital discharge. If the infant's growth is acceptable, the proportion of feeds from direct breastfeeding may be gradually increased while feeds of fortified expressed milk are gradually decreased. (See
         <a class="medical medical_review" href="/z/d/html/5014.html" rel="external">
          "Approach to enteral nutrition in the premature infant", section on 'Infants who can feed orally'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3438771134">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111345.html" rel="external">
          "Society guideline links: Breastfeeding and infant nutrition"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/143917.html" rel="external">
          "Society guideline links: Nutrition support (parenteral and enteral nutrition) for neonates including preterm infants"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Benefits of mother's milk
         </strong>
         – We recommend mother's own milk rather than preterm formula for premature infants (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). Compared with preterm formula, mother's milk feeds are associated with reduced rates of necrotizing enterocolitis (NEC), late-onset sepsis, and possibly chronic lung disease, as well as improved neurodevelopment. (See
         <a class="local">
          'Benefits of mother's milk'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lactation support
         </strong>
         – Because mother's own milk has the most health benefits for the infant, every effort should be made to support effective lactation by the birth mother. This typically involves early and frequent breast milk expression using a breast pump, enhanced by focused lactational counseling. (See
         <a class="medical medical_review" href="/z/d/html/5044.html" rel="external">
          "Breast milk expression for the preterm infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role for donor milk
         </strong>
         – When mother's own milk is not available for very low birth weight (VLBW) infants or other infants with a high risk of NEC, we suggest feeding with pasteurized milk from a human donor rather than preterm formula (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). Donor milk is associated with decreased risk of NEC and feeding intolerance compared with preterm formula. Donor milk is inferior to mother's milk because it is not associated with some other health benefits and it has somewhat lower quantities of protein and energy. Donor milk can be continued for the duration in which VLBW infants are at risk for NEC, which is through approximately 32 to 34 weeks corrected gestational age. (See
         <a class="local">
          'Use of donor milk'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fortification of human milk
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Human milk feedings for VLBW infants and other preterm infants at risk of growth failure must be fortified with a human milk fortifier (HMF) to meet their nutritional needs. Commercially available HMFs vary in multiple ways  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 2
         </a>
         ). We suggest liquid preparations of HMFs due to concern for transmission of
         <em>
          Cronobacter
         </em>
         <em>
          sakazakii
         </em>
         in powdered HMFs, based on limited evidence from anecdotal reports (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Clear advantages of protein hydrolysis or human-derived HMF over bovine-derived HMF have not been shown. (See
         <a class="local">
          'Indications and fortifier types'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Decisions about continuing HMFs after hospital discharge depend on the growth status of the infant and the mother's goals for lactation, direct breastfeeding, and bottle feeding. (See
         <a class="local">
          'Post-discharge fortifier use'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5014.html" rel="external">
          "Approach to enteral nutrition in the premature infant", section on 'Infants who can feed orally'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1152712394">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Richard J Schanler, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Parker MG, Stellwagen LM, Noble L, et al. Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant. Pediatrics 2021; 148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meek JY, Noble L, Section on  Breastfeeding. Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics 2022; 150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           COMMITTEE ON NUTRITION, SECTION ON BREASTFEEDING, COMMITTEE ON FETUS AND NEWBORN. Donor Human Milk for the High-Risk Infant: Preparation, Safety, and Usage Options in the United States. Pediatrics 2017; 139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am 2013; 60:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gomez-Gallego C, Garcia-Mantrana I, Salminen S, Collado MC. The human milk microbiome and factors influencing its composition and activity. Semin Fetal Neonatal Med 2016; 21:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meinzen-Derr J, Poindexter B, Wrage L, et al. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol 2009; 29:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sisk PM, Lambeth TM, Rojas MA, et al. Necrotizing Enterocolitis and Growth in Preterm Infants Fed Predominantly Maternal Milk, Pasteurized Donor Milk, or Preterm Formula: A Retrospective Study. Am J Perinatol 2017; 34:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quigley M, Embleton ND, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2019; 7:CD002971.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strobel NA, Adams C, McAullay DR, Edmond KM. Mother's Own Milk Compared With Formula Milk for Feeding Preterm or Low Birth Weight Infants: Systematic Review and Meta-analysis. Pediatrics 2022; 150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corpeleijn WE, Kouwenhoven SM, Paap MC, et al. Intake of own mother's milk during the first days of life is associated with decreased morbidity and mortality in very low birth weight infants during the first 60 days of life. Neonatology 2012; 102:276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999; 103:1150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller J, Tonkin E, Damarell RA, et al. A Systematic Review and Meta-Analysis of Human Milk Feeding and Morbidity in Very Low Birth Weight Infants. Nutrients 2018; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vohr BR, Poindexter BB, Dusick AM, et al. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics 2006; 118:e115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vohr BR, Poindexter BB, Dusick AM, et al. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics 2007; 120:e953.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belfort MB, Anderson PJ, Nowak VA, et al. Breast Milk Feeding, Brain Development, and Neurocognitive Outcomes: A 7-Year Longitudinal Study in Infants Born at Less Than 30 Weeks' Gestation. J Pediatr 2016; 177:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patra K, Hamilton M, Johnson TJ, et al. NICU Human Milk Dose and 20-Month Neurodevelopmental Outcome in Very Low Birth Weight Infants. Neonatology 2017; 112:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yackobovitch-Gavan M, Atia Shmueli S, Morag I. Neurodevelopmental Outcomes Among Infants Born Preterm Fed With Mother's Own Milk: A Comparison of Singletons and Twins. J Pediatr 2023; 259:113484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobi-Polishook T, Collins CT, Sullivan TR, et al. Human milk intake in preterm infants and neurodevelopment at 18 months corrected age. Pediatr Res 2016; 80:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Isaacs EB, Fischl BR, Quinn BT, et al. Impact of breast milk on intelligence quotient, brain size, and white matter development. Pediatr Res 2010; 67:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker MG, Greenberg LT, Edwards EM, et al. National Trends in the Provision of Human Milk at Hospital Discharge Among Very Low-Birth-Weight Infants. JAMA Pediatr 2019; 173:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ESPGHAN Committee on Nutrition, Arslanoglu S, Corpeleijn W, et al. Donor human milk for preterm infants: current evidence and research directions. J Pediatr Gastroenterol Nutr 2013; 57:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker MG, Burnham LA, Kerr S, et al. Prevalence and predictors of donor milk programs among U.S. advanced neonatal care facilities. J Perinatol 2020; 40:672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010; 156:562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Connor DL, Gibbins S, Kiss A, et al. Effect of Supplemental Donor Human Milk Compared With Preterm Formula on Neurodevelopment of Very Low-Birth-Weight Infants at 18 Months: A Randomized Clinical Trial. JAMA 2016; 316:1897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cristofalo EA, Schanler RJ, Blanco CL, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr 2013; 163:1592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corpeleijn WE, de Waard M, Christmann V, et al. Effect of Donor Milk on Severe Infections and Mortality in Very Low-Birth-Weight Infants: The Early Nutrition Study Randomized Clinical Trial. JAMA Pediatr 2016; 170:654.
          </a>
         </li>
         <li class="breakAll">
          Human Milk Banking Association of North America. HMBANA Standards for Donor Human Milk Banking: An Overview. 2020. Available at: https://www.hmbana.org/file_download/inline/95a0362a-c9f4-4f15-b9ab-cf8cf7b7b866 (Accessed on January 29, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pound C, Unger S, Blair B. Pasteurized and unpasteurized donor human milk. Paediatr Child Health 2020; 25:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subudhi S, Sriraman N. Islamic Beliefs About Milk Kinship and Donor Human Milk in the United States. Pediatrics 2021; 147.
          </a>
         </li>
         <li class="breakAll">
          AAP Committee on Nutrition. Pediatric Nutrition, 8th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, 2019.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gidrewicz DA, Fenton TR. A systematic review and meta-analysis of the nutrient content of preterm and term breast milk. BMC Pediatr 2014; 14:216.
          </a>
         </li>
         <li class="breakAll">
          Pediatric Nutrition Practice Group. Infant and Pediatric Feedings: Guidelines for Preparation of Human Milk and Formula in Health Care Facilities, 3rd ed, Steele C, Collins E (Eds), Academy of Nutrition and Dietetics, 2018.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooper AR, Barnett D, Gentles E, et al. Macronutrient content of donor human breast milk. Arch Dis Child Fetal Neonatal Ed 2013; 98:F539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henderson TR, Fay TN, Hamosh M. Effect of pasteurization on long chain polyunsaturated fatty acid levels and enzyme activities of human milk. J Pediatr 1998; 132:876.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zozaya C, García-Serrano A, Fontecha J, et al. Fat Loss in Continuous Enteral Feeding of the Preterm Infant: How Much, What and When Is It Lost? Nutrients 2018; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belfort MB, Edwards EM, Greenberg LT, et al. Diet, weight gain, and head growth in hospitalized US very preterm infants: a 10-year observational study. Am J Clin Nutr 2019; 109:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol 2016; 36:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown JV, Embleton ND, Harding JE, McGuire W. Multi-nutrient fortification of human milk for preterm infants. Cochrane Database Syst Rev 2016; :CD000343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haston JC, Miko S, Cope JR, et al. Cronobacter sakazakii Infections in Two Infants Linked to Powdered Infant Formula and Breast Pump Equipment - United States, 2021 and 2022. MMWR Morb Mortal Wkly Rep 2023; 72:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jason J. Prevention of invasive Cronobacter infections in young infants fed powdered infant formulas. Pediatrics 2012; 130:e1076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Enterobacter sakazakii infections associated with the use of powdered infant formula--Tennessee, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:297.
          </a>
         </li>
         <li class="breakAll">
          US Food and Drug Administration. FDA Warns Consumers Not to Use Certain Powdered Infant Formula Produced in Abbott Nutrition's Facility in Sturgis, Michigan. 2022. Available at: https://www.fda.gov/news-events/press-announcements/fda-warns-consumers-not-use-certain-powdered-infant-formula-produced-abbott-nutritions-facility (Accessed on February 18, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bingham R, Pineda D, Gates A, et al. Displacement of human milk during fortification: An experimental study. JPEN J Parenter Enteral Nutr 2023; 47:1062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gao C, Miller J, Collins CT, Rumbold AR. Comparison of different protein concentrations of human milk fortifier for promoting growth and neurological development in preterm infants. Cochrane Database Syst Rev 2020; 11:CD007090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JH, Chan G, Schanler R, et al. Growth and Tolerance of Preterm Infants Fed a New Extensively Hydrolyzed Liquid Human Milk Fortifier. J Pediatr Gastroenterol Nutr 2015; 61:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordova EG, Soldateli B, Rosner B, et al. Growth and Clinical Outcomes of Very Low-Birth-Weight Infants Receiving Acidified vs Nonacidified Liquid Human Milk Fortifiers. Nutr Clin Pract 2021; 36:1304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Connor DL, Kiss A, Tomlinson C, et al. Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing &lt;1250 g: a randomized clinical trial. Am J Clin Nutr 2018; 108:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas A, Assad M, Sherman J, et al. Safety of Cow's Milk-Derived Fortifiers Used with an All-Human Milk Base Diet in Very Low Birthweight Preterm Infants. Neonatal Today 2020; 15:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas A, Assad M, Sherman J, et al. Safety of Cow's Milk-Derived Fortifiers used with an All Human Milk Base Diet in Very Low Birthweight Preterm Infants: Part II. Neonatal Today 2020; 15:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas A, Boscardin J, Abrams SA. Preterm Infants Fed Cow's Milk-Derived Fortifier Had Adverse Outcomes Despite a Base Diet of Only Mother's Own Milk. Breastfeed Med 2020; 15:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hampson G, Roberts SLE, Lucas A, Parkin D. An economic analysis of human milk supplementation for very low birth weight babies in the USA. BMC Pediatr 2019; 19:337.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Pediatric Nutrition Handbook, 7th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, 2014.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah SD, Dereddy N, Jones TL, et al. Early versus Delayed Human Milk Fortification in Very Low Birth Weight Infants-A Randomized Controlled Trial. J Pediatr 2016; 174:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alizadeh Taheri P, Sajjadian N, Asgharyan Fargi M, Shariat M. Is early breast milk fortification more effective in preterm infants?: a clinical trial. J Perinat Med 2017; 45:953.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rochow N, Fusch G, Choi A, et al. Target fortification of breast milk with fat, protein, and carbohydrates for preterm infants. J Pediatr 2013; 163:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horbar JD, Ehrenkranz RA, Badger GJ, et al. Weight Growth Velocity and Postnatal Growth Failure in Infants 501 to 1500 Grams: 2000-2013. Pediatrics 2015; 136:e84.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5050 Version 48.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34635582" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35921640" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Policy Statement: Breastfeeding and the Use of Human Milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27994111" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Donor Human Milk for the High-Risk Infant: Preparation, Safety, and Usage Options in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23178060" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Human milk composition: nutrients and bioactive factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27286644" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The human milk microbiome and factors influencing its composition and activity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18716628" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27936476" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Necrotizing Enterocolitis and Growth in Preterm Infants Fed Predominantly Maternal Milk, Pasteurized Donor Milk, or Preterm Formula: A Retrospective Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31322731" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Formula versus donor breast milk for feeding preterm or low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35921674" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Mother's Own Milk Compared With Formula Milk for Feeding Preterm or Low Birth Weight Infants: Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22922675" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Intake of own mother's milk during the first days of life is associated with decreased morbidity and mortality in very low birth weight infants during the first 60 days of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10353922" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29857555" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : A Systematic Review and Meta-Analysis of Human Milk Feeding and Morbidity in Very Low Birth Weight Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16818526" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17908750" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27480198" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Breast Milk Feeding, Brain Development, and Neurocognitive Outcomes: A 7-Year Longitudinal Study in Infants Born at Less Than 30 Weeks' Gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28768286" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : NICU Human Milk Dose and 20-Month Neurodevelopmental Outcome in Very Low Birth Weight Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37196779" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Neurodevelopmental Outcomes Among Infants Born Preterm Fed With Mother's Own Milk: A Comparison of Singletons and Twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27356082" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Human milk intake in preterm infants and neurodevelopment at 18 months corrected age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20035247" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Impact of breast milk on intelligence quotient, brain size, and white matter development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31479097" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : National Trends in the Provision of Human Milk at Hospital Discharge Among Very Low-Birth-Weight Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24084373" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Donor human milk for preterm infants: current evidence and research directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32103161" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Prevalence and predictors of donor milk programs among U.S. advanced neonatal care facilities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20036378" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27825008" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Effect of Supplemental Donor Human Milk Compared With Preterm Formula on Neurodevelopment of Very Low-Birth-Weight Infants at 18 Months: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23968744" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27135598" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Effect of Donor Milk on Severe Infections and Mortality in Very Low-Birth-Weight Infants: The Early Nutrition Study Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27135598" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Effect of Donor Milk on Severe Infections and Mortality in Very Low-Birth-Weight Infants: The Early Nutrition Study Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33365109" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Pasteurized and unpasteurized donor human milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33483451" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Islamic Beliefs About Milk Kinship and Donor Human Milk in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33483451" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Islamic Beliefs About Milk Kinship and Donor Human Milk in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25174435" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : A systematic review and meta-analysis of the nutrient content of preterm and term breast milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25174435" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : A systematic review and meta-analysis of the nutrient content of preterm and term breast milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23867707" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Macronutrient content of donor human breast milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9602205" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Effect of pasteurization on long chain polyunsaturated fatty acid levels and enzyme activities of human milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29937492" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Fat Loss in Continuous Enteral Feeding of the Preterm Infant: How Much, What and When Is It Lost?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30997514" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Diet, weight gain, and head growth in hospitalized US very preterm infants: a 10-year observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26562370" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27155888" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Multi-nutrient fortification of human milk for preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36862586" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Cronobacter sakazakii Infections in Two Infants Linked to Powdered Infant Formula and Breast Pump Equipment - United States, 2021 and 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23045556" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Prevention of invasive Cronobacter infections in young infants fed powdered infant formulas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12002167" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Enterobacter sakazakii infections associated with the use of powdered infant formula--Tennessee, 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12002167" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Enterobacter sakazakii infections associated with the use of powdered infant formula--Tennessee, 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37488685" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Displacement of human milk during fortification: An experimental study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33215474" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Comparison of different protein concentrations of human milk fortifier for promoting growth and neurological development in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26488118" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Growth and Tolerance of Preterm Infants Fed a New Extensively Hydrolyzed Liquid Human Milk Fortifier.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32840926" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Growth and Clinical Outcomes of Very Low-Birth-Weight Infants Receiving Acidified vs Nonacidified Liquid Human Milk Fortifiers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29878061" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing&lt;1250 g: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Safety of Cow's Milk-Derived Fortifiers Used with an All-Human Milk Base Diet in Very Low Birthweight Preterm Infants
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Safety of Cow's Milk-Derived Fortifiers used with an All Human Milk Base Diet in Very Low Birthweight Preterm Infants: Part II
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32239968" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Preterm Infants Fed Cow's Milk-Derived Fortifier Had Adverse Outcomes Despite a Base Diet of Only Mother's Own Milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31521145" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : An economic analysis of human milk supplementation for very low birth weight babies in the USA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31521145" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : An economic analysis of human milk supplementation for very low birth weight babies in the USA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27112041" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Early versus Delayed Human Milk Fortification in Very Low Birth Weight Infants-A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27676603" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Is early breast milk fortification more effective in preterm infants?: a clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23769498" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Target fortification of breast milk with fat, protein, and carbohydrates for preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26101360" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Weight Growth Velocity and Postnatal Growth Failure in Infants 501 to 1500 Grams: 2000-2013.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
